Herein, we found that the S87 site of DHX9 between the two DSRM domains of DHX9 demonstrated a higher phosphorylation level in breast cancer, ovarian cancer and colon cancer than those in normal tissues (Figures 3A, B). Here, DHX9 is linked to breast carcinoma.